Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT06723795

Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes

Led by Tel-Aviv Sourasky Medical Center · Updated on 2025-09-30

150

Participants Needed

1

Research Sites

126 weeks

Total Duration

On this page

Sponsors

T

Tel-Aviv Sourasky Medical Center

Lead Sponsor

A

AstraZeneca

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a research study involving patients hospitalized for COPD flare-ups. Patients will be randomly assigned to two groups: one group will only see a pulmonologist (lung doctor), and the other group will also be seen by a cardiologist (heart doctor) during their hospital stay. Both groups will fill out a questionnaire, and the pulmonologist will review their lung disease, adjust their treatment, and recommend follow-up care. The cardiologist will also assess the second group for heart diseases (like high cholesterol, diabetes, heart disease, high blood pressure, or heart failure) and start or adjust heart treatment if needed. Both groups will be followed up by phone 1, 3, 6 and 12 months later to check for changes in treatment, new heart problems, COPD flare-ups, or death.

CONDITIONS

Official Title

Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Documented COPD based on lung function tests, symptoms, and relevant treatment
  • Age between 18 and 75 years
  • Mentally competent to understand and follow medical recommendations
Not Eligible

You will not qualify if you...

  • Under 18 years of age
  • Unable to provide consent
  • Unstable concurrent disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tel-Aviv Sourasky Medical Center

Tel Aviv, Israel

Actively Recruiting

Loading map...

Research Team

O

Ophir Freund, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SCREENING

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes | DecenTrialz